Law360, New York (June 12, 2009) -- In its ongoing bid to protect Solodyn from generic competitors, skin health specialist Medicis Pharmaceutical Corp. has accused Indian generics maker Ranbaxy Laboratories Ltd. of infringing a patent for the popular acne medication.
The complaint, filed Thursday in the U.S. District Court for the District of Delaware, alleges that an abbreviated new drug application Ranbaxy Labs filed with the U.S. Food and Drug...
